SCHEMBL40498

SCHEMBL40498

O=C(O)COC(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.50
ALOX15 P16050 1/20 0.48
CYP2C19 P33261 1/20 0.45
HIF1A Q16665 1/20 0.45
PAM P19021 1/20 0.42
ALDH1A1 P00352 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
POLB P06746 1/20 0.41
TSHR P16473 1/20 0.41
GLA P06280 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
KCNN4 O15554 1/20 0.41
PTPN7 P35236 2/20 0.40
FFAR1 O14842 1/20 0.40
CYP1A2 P05177 1/20 0.40
SLC6A1 P30531 1/20 0.40
KMT2A Q03164 2/20 0.39
PTGDR2 Q9Y5Y4 2/20 0.39
MEN1 O00255 1/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6707492 0.86 SLC6A1 (0.49) KIF11SMN1; SMN2POLBCYP1A2SLC6A1
SCHEMBL26626984 0.86 SLC6A1 (0.49) KIF11SMN1; SMN2POLBCYP1A2SLC6A1
SCHEMBL17965751 0.85 KIF11 (0.48) KIF11ALOX15CYP2C19HIF1AALDH1A1
SCHEMBL10334599 0.85 PTGDR2 (0.49) ALDH1A1SMN1; SMN2FFAR1KMT2APTGDR2
SCHEMBL7057598 0.83 KIF11 (0.47) KIF11ALOX15CYP2C19HIF1AALDH1A1
SCHEMBL17237864 0.83 KIF11 (0.47) KIF11ALOX15CYP2C19HIF1AALDH1A1
SCHEMBL7054160 0.83 KIF11 (0.47) KIF11ALOX15CYP2C19HIF1APAM
SCHEMBL9548452 0.83 KIF11 (0.47) KIF11ALOX15CYP2C19HIF1AALDH1A1
SCHEMBL28446874 0.83 KIF11 (0.52) KIF11CYP2C19HIF1AALDH1A1SMN1; SMN2
SCHEMBL7055637 0.83 KIF11 (0.47) KIF11ALOX15CYP2C19HIF1AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 5844 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260035402-A1 C10-ALKYLENE SUBSTITUTED 13-MEMBERED MACROLIDES AND USES THEREOF ZIKANI THERAPEUTICS INC (US) 2026-02-05 US claimed
EP-3947382-B1 COMPOUNDS FOR USES IN PHARMACOLOGICAL INDUCTION OF HBF FOR TREATMENT OF SICKLE CELL DISEASE AND BETA-THALASSEMIA ACADEMIA SINICA (TW) 2025-09-24 EP claimed
US-12060334-B2 3-substituted phenazine derivatives as antimicrobial agents UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2024-08-13 US claimed
EP-2991655-B1 COMPOSITIONS AND METHODS FOR ALTERING SECOND MESSENGER SIGNALING MEMORIAL SLOAN KETTERING CANCER CENTER (US) 2024-04-10 EP claimed
EP-3606528-B1 TRICYCLIC COMPOUNDS AS GLYCOGEN SYNTHASE KINASE 3 (GSK3) INHIBITORS AND USES THEREOF BROAD INST INC (US) 2023-10-18 EP claimed
US-11634449-B2 Macrolides and methods of their preparation and use PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2023-04-25 US claimed
CN-115611933-A Process for preparing arginase inhibitors and synthetic intermediates thereof 因赛特公司 2023-01-17 CN claimed
EP-3649135-B1 SYNTHESIS OF HALICHONDRINS HARVARD COLLEGE (US) 2022-12-28 EP claimed
US-20220332747-A1 MACROLIDES AND METHODS OF THEIR PREPARATION AND USE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2022-10-20 US claimed
EP-3291676-B1 MITRAGYNINE ANALOGS AND USES THEREOF MEMORIAL SLOAN KETTERING CANCER CENTER (US) 2022-08-17 EP claimed
EP-2037762-A4 METHOD TO PREPARE PURE CURCUMIN KIM DARRICK S H L (US) 2009-07-08 EP claimed
EP-2037762-A1 METHOD TO PREPARE PURE CURCUMIN Kim, Darrick S.H.L. (US) 2009-03-25 EP claimed
WO-2007143635-A1 METHOD TO PREPARE PURE CURCUMIN KIM DARRICK S (US) 2007-12-13 WO claimed
EP-1775299-A1 Process for the synthesis of HMG-CoA reductase inhibitors LEK Pharmaceuticals D.D. (SI) 2007-04-18 EP claimed
EP-0781293-A4 COMPOSITIONS FOR ENZYME CATALYZED TEMPLATE-INDEPENDENT CREATION OF PHOSPHODIESTER BONDS USING PROTECTED NUCLEOTIDES HIATT ANDREW C ROSE HIATT BIOT (US) 1999-05-26 EP claimed
US-5808045-A Compositions for enzyme catalyzed template-independent creation of phosphodiester bonds using protected nucleotides Hiatt, Andrew C. (US) 1998-09-15 US claimed
EP-0781293-A1 COMPOSITIONS FOR ENZYME CATALYZED TEMPLATE-INDEPENDENT CREATION OF PHOSPHODIESTER BONDS USING PROTECTED NUCLEOTIDES Hiatt, Andrew C. (US) 1997-07-02 EP claimed
WO-1996007669-A1 COMPOSITIONS FOR ENZYME CATALYZED TEMPLATE-INDEPENDENT CREATION OF PHOSPHODIESTER BONDS USING PROTECTED NUCLEOTIDES ROSE-HIATT BIOTECHNOLOGY PARTNERSHIP (US) 1996-03-14 WO claimed
US-5478928-A Useful as antiviral agents in the treatment and prevention of AIDS SOUTHERN RESEARCH INSTITUTE (US) 1995-12-26 US claimed
WO-1995011685-A1 2',3'-DIDEOXY-4'-THIORIBONUCLEOSIDES AS ANTIVIRAL AGENTS SOUTHERN RESEARCH INSTITUTE (US) 1995-05-04 WO claimed